iBio
IBIO
10 hedge funds and large institutions have $349K invested in iBio in 2013 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
11% more funds holding
Funds holding: 9 → 10 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
32% less capital invested
Capital invested by funds: $512K → $349K (-$163K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$12.8K |
| 2 |
Morgan Stanley
New York
|
+$3.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$54.6K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$9.11K |
IBIO Hedge Fund Activity: Q4 2013 in Review
10 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q4 2013, worth a combined $349K — down 32% from $512K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new IBIO positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $12.8K. The largest seller was Perkins Capital Management, cutting an estimated $54.6K.
- 10 institutional investors held iBio (IBIO) as of Q4 2013, up from 9 in Q3 2013.
- Funds reported $349K of iBio stock for Q4 2013, down 32% quarter-over-quarter.
- 1 fund opened new iBio positions in Q4 2013 and 0 closed out, a net change of +1 holder.
- The largest iBio buyer in Q4 2013 was Citadel Advisors, an estimated $12.8K added.
- The largest iBio seller in Q4 2013 was Perkins Capital Management, an estimated $54.6K sold.
Based on aggregated 13F filings for Q4 2013.